New Report by National Families in Action Rips the Veil Off

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
31
New Report by National Families in Action Rips the Veil Off the Medical Marijuana Industry
  • Tracking the Money That’s Legalizing Marijuana and Why It Matters  documents state-by-state financial data, exposing the groups and the amount of money used either to fund or oppose ballot initiatives legalizing medical or recreational marijuana in 16 U.S. states.
  • NFIA report reveals three billionaires -- George Soros, Peter Lewis and John Sperling -- who contributed 80 percent of the money to medicalize marijuana through state ballot initiatives during a 13-year period, with the strategy to use medical marijuana as a runway to legalized recreational pot.
  • Report shows how billionaires and marijuana legalizers manipulated the ballot initiative process, outspent the people who opposed marijuana and convinced voters that marijuana is medicine, even while most of the scientific and medical communities say marijuana is not medicine and should not be legal.
  • Children in Colorado treated with unregulated cannabis oil have had severe dystonic reactions, other movement disorders, developmental regression, intractable vomiting and worsening seizures.
  • A medical marijuana industry has emerged to join the billionaires in financing initiatives to legalize recreational pot.

ATLANTA, March 14, 2017 (GLOBE NEWSWIRE) -- A new report by National Families in Action (NFIA) uncovers and documents how three billionaires, who favor legal recreational marijuana, manipulated the ballot initiative process in 16 U.S. states for more than a decade, convincing voters to legalize medical marijuana. NFIA is an Atlanta-based nonprofit organization, founded in 1977, that has been helping parents prevent children from using alcohol, tobacco, and other drugs.  NFIA researched and issued the paper to mark its 40 th anniversary.

The NFIA study, Tracking the Money That’s Legalizing Marijuana and Why It Matters , exposes, for the first time, the money trail behind the marijuana legalization effort during a 13-year period. The report lays bare the strategy to use medical marijuana as a runway to legalized recreational pot, describing how financier George Soros, insurance magnate Peter Lewis, and for-profit education baron John Sperling (and groups they and their families fund) systematically chipped away at resistance to marijuana while denying that full legalization was their goal.

The report documents state-by-state financial data, identifying the groups and the amount of money used either to fund or oppose ballot initiatives legalizing medical or recreational marijuana in 16 states. The paper unearths how legalizers fleeced voters and outspent -- sometimes by hundreds of times -- the people who opposed marijuana.

Tracking the Money That’s Legalizing Marijuana and Why It Matters illustrates that legalizers lied about the health benefits of marijuana, preyed on the hopes of sick people, flouted scientific evidence and advice from the medical community and gutted consumer protections against unsafe, ineffective drugs.  And, it proves that once the billionaires achieved their goal of legalizing recreational marijuana (in Colorado and Washington in 2012), they virtually stopped financing medical pot ballot initiatives and switched to financing recreational pot.  In 2014 and 2016, they donated $44 million to legalize recreational pot in Alaska, Oregon, California, Arizona, Nevada, Massachusetts and Maine. Only Arizona defeated the onslaught (for recreational marijuana). 

Unravelling the Legalization Strategy:  Behind the Curtain In 1992, financier George Soros contributed an estimated $15 million to several groups he advised to stop advocating for outright legalization and start working toward what he called more winnable issues such as medical marijuana.  At a press conference in 1993, Richard Cowen, then-director of the National Organization for the Reform of Marijuana Laws, said, “The key to it [full legalization] is medical access. Because, once you have hundreds of thousands of people using marijuana medically, under medical supervision, the whole scam is going to be blown. The consensus here is that medical marijuana is our strongest suit. It is our point of leverage which will move us toward the legalization of marijuana for personal use.” 

Between 1996 and 2009, Soros, Lewis and Sperling contributed 80 percent of the money to medicalize marijuana through state ballot initiatives.  Their financial contributions, exceeding $15.7 million (of the $19.5 million total funding), enabled their groups to lie to voters in advertising campaigns, cover up marijuana’s harmful effects, and portray pot as medicine -- leading people to believe that the drug is safe and should be legal for any use. 

Today, polls show how successful the billionaires and their money have been. In 28 U.S. states and the District of Columbia, voters and, later, legislators have shown they believe marijuana is medicine, even though most of the scientific and medical communities say marijuana is not medicine and should not be legal. While the most recent report, issued by the National Academies of Sciences (NAS), finds that marijuana may alleviate certain kinds of pain, it also finds there is no rigorous, medically acceptable documentation that marijuana is effective in treating any other illness.  At the same time, science offers irrefutable evidence that marijuana is addictive, harmful and can hinder brain development in adolescents.  At the distribution level, there are no controls on the people who sell to consumers.  Budtenders (marijuana bartenders) have no medical or pharmaceutical training or qualifications.

One tactic used by legalizers was taking advantage of voter empathy for sick people, along with the confusion about science and how the FDA approves drugs.  A positive finding in a test tube or petri dish is merely a first step in a long, rigorous process leading to scientific consensus about the efficacy of a drug.  Scientific proof comes after randomized, controlled clinical trials, and many drugs with promising early stage results never make it through the complex sets of hurdles that prove efficacy and safety.  But marijuana legalizers use early promise and thin science to persuade and manipulate empathetic legislators and voters into buying the spin that marijuana is a cure-all. 

People who are sick already have access to two FDA-approved drugs, dronabinol and nabilone, that are not marijuana, but contain identical copies of some of the components of marijuana.  These drugs, available as pills, effectively treat chemotherapy-induced nausea and vomiting and AIDS wasting.  The NAS reviewed 10,700 abstracts of marijuana studies conducted since 1999, finding that these two oral drugs are effective in adults for the conditions described above. An extract containing two marijuana chemicals that is approved in other countries, reduces spasticity caused by multiple sclerosis.  But there is no evidence that marijuana treats other diseases, including epilepsy and most of the other medical conditions the states have legalized marijuana to treat.  These conditions range from Amyotrophic lateral sclerosis (ALS) and Crohn’s disease to Hepatitis-C, post-traumatic stress disorder (PTSD) and even sickle cell disease.

Not So Fast -- What about the Regulations? Legalizers also have convinced Americans that unregulated cannabidiol, a marijuana component branded as cannabis oil, CBD, or Charlotte’s Web, cures intractable seizures in children with epilepsy, and polls show some 90 percent of Americans want medical marijuana legalized, particularly for these sick children.  In Colorado, the American Epilepsy Society reports that children with epilepsy are receiving unregulated, highly variable artisanal preparations of cannabis oil recommended, in most cases, by doctors with no training in pediatrics, neurology or epilepsy.  Young patients have had severe dystonic reactions and other movement disorders, developmental regression, intractable vomiting and worsening seizures that can be so severe that their physicians have to put the child into a coma to get the seizures to stop.  Because of these dangerous side effects, not one pediatric neurologist in Colorado, where unregulated cannabidiol is legal, recommends it for these children.

Dr. Sanjay Gupta further clouded the issue when he produced Weed in 2013, a three-part documentary series for CNN on marijuana as medicine.  In all three programs, Dr. Gupta promoted CBD oil, the kind the American Epilepsy Society calls artisanal. This is because not one CBD product sold in legal states has been purified to Food and Drug Administration (FDA) standards, tested, or proven safe and effective.  The U.S. Congress and the FDA developed rigid processes to review drugs and prevent medical tragedies such as birth defects caused by thalidomide. These processes have facilitated the greatest advances in medicine in history. 

“By end-running the FDA, three billionaires have been willing to wreck the drug approval process that has protected Americans from unsafe, ineffective drugs for more than a century,” said Sue Rusche, president and CEO of National Families in Action and author of the report.  “Unsubstantiated claims for the curative powers of marijuana abound.” No one can be sure of the purity, content, side effects or potential of medical marijuana to cause cancer or any other disease. When people get sick from medical marijuana, there are no uniform mechanisms to recall products causing the harm. Some pot medicines contain no active ingredients. Others contain contaminants. “Sick people, especially children, suffer while marijuana medicine men make money at their expense,” added Ms. Rusche.

Marijuana Industry -- Taking a Page from the Tobacco Industry The paper draws a parallel between the marijuana and tobacco industries, both built with the knowledge that a certain percentage of users will become addicted and guaranteed lifetime customers.  Like tobacco, legalized marijuana will produce an unprecedented array of new health, safety and financial consequences to Americans and their children. 

“Americans learned the hard way about the tragic effects of tobacco and the deceptive practices of the tobacco industry.  Making another addictive drug legal unleashes a commercial business that is unable to resist the opportunity to make billions of dollars on the back of human suffering, unattained life goals, disease, and death,” said Ms. Rusche.  “If people genuinely understood that marijuana can cause cognitive, safety and mental health problems, is addictive, and that addiction rates may be three times higher than reported, neither voters nor legislators would legalize pot.” 

The paper and the supporting data are available at www.nationalfamilies.org . 

About National Families in Action National Families in Action is a 501 (c) (3) nonprofit organization that was founded in Atlanta, Georgia in 1977. The organization helped lead a national parent movement credited with reducing drug use among U.S. adolescents and young adults by two-thirds between 1979 and 1992. For forty years, it has provided complex scientific information in understandable language to help parents and others protect children’s health. It tracks marijuana science and the marijuana legalization movement on its Marijuana Report website and its weekly e-newsletter of the same name.

Media Contacts Jeannine Addams Kristin Wohlleben J. Addams & Partners, Inc. 404.231.1132 phone jfaddams@jaddams.com kwohlleben@jaddams.com Sue Rusche, President and CEO National Families in Action 404.248.9676 phone srusche@nationalfamilies.org

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Diwali Celebration in Chicago Honors Indian Community

Updated Category News Views 142

Chicago's Diwali Tribute: Music, Dance, and Diversity Talk about spreading the glow! On November 13, 2026, Cook County Treasurer Maria Pappas is gearing up to throw a Diwali bash that'll light up Chicago's cultural landscape. Alongside Indian Consul General Dr. M. Anand Prakash, she's orchestrating a vibrant affair designed to spotlight Indian American community leaders...

Continue Reading
AI Governance: Banks' Secret to Successful Scaling

Updated Category News Views 90

AI in Banking: Cautious Steps Forward Banks aren't exactly racing with AI; they're inching forward. With AI agents entering the picture, you'd think the buzz would be about groundbreaking deployments. Instead, the story here is more about banks holding their cards close to the vest. Agentic AI, with its ability to plan and act without a human babysitter at every step, is...

Continue Reading
Kentucky Power's Bold Plan to Boost Local Economy

Updated Category News Views 93

Electricity, Economy, and Execution Kentucky Power just laid out plans that could massively swing the pendulum for eastern Kentucky's economic prospects. They've put filings on the table for the Kentucky Public Service Commission that, if approved, promise big economic benefits. We're talking about a potential infusion of $500 million through fixed-rate offsets and an...

Continue Reading
POWERCHINA's Clean Energy Initiatives at COP31 Spotlighted

Updated Category News Views 136

A Global Push for Clean Energy: POWERCHINA's Role Picture this: a bustling global scene at the United Nations Climate Change Conference, COP31, in Antalya, with leaders huddling over the future of our planet's energy. Meanwhile, Power Construction Corporation of China (POWERCHINA) is out there in the trenches, muscling through the monumental task of turning ambitious...

Continue Reading
Palatin Prepares for FY27 Results Amid Market Curiosity

Updated Category News Views 51

Mark Your Calendars, Investors! Folks grumble about the mundane task of checking fiscal calendars, but without this intel, where are we? On November 17, 2026, Palatin Technologies (NASDAQ:PTN) is slated to release their Q1 Fiscal Year 2027 operating results bright and early, before most of us have even sipped our coffee. The buzz around these numbers is as electric as any...

Continue Reading
Classic vs. Youngtimer Cars: Evolution in Collecting

Updated Category News Views 90

The Collector's Journey: Classic Cars vs. Youngtimers Ever notice how car collecting has its own circles of fame? You're either basking in the glow of a vintage classic or eyeing a youngtimer that’s just catching steam. In this article from HelloNation, Engels Gualdani — the classic car sage of Hilton, NY — helps untangle these categories for us, and it’s a lesson...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 28

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
NueSynergy Secures Top Spot in HSA Provider Rankings

Updated Category News Views 107

NueSynergy Earns its Stripes in 2026 It seems these days, healthcare costs are rising faster than you can say 'deductible.' In this chaotic landscape, a good HSA provider is worth its weight in gold. Enter NueSynergy, whose efforts have once again been acknowledged by Morningstar, a big name in the world of investment research. What Sets NueSynergy Apart? NueSynergy isn't...

Continue Reading
Noël Jolié's Cream Earns Spot on Oprah's List

Updated Category News Views 79

The Powerhouse of Oprah's Seal of Approval Ever notice what happens when Oprah drops a nod towards any brand? It's like Midas touching everything gold. That's exactly the scenario with Noël Jolié, a Chicago-based luxury body care operation, hitting the jackpot by landing its Velours Silken Body Cream on Oprah's Favorite Things 2026. You can't buy this kind of press,...

Continue Reading
Secrets to Selecting Fresh Seafood for Your Boil

Updated Category News Views 85

Navigating the Waters of Seafood Quality When it comes to throwing together a proper Louisiana seafood boil, your whole evening could sink or swim based on seafood freshness. Jonathan Sumich, a grocery veteran from Oak Point Fresh Market, spills the beans on picking the cream of the crop. Plan it right, and you’re the hero of the feast. Ignore these tips, and you might...

Continue Reading

Top 5 Most Recently Viewed Articles

Uncovering North Korea's Cryptocurrency Heists of 2024

Updated Category News Views 160

Overview of the Cyber Threats North Korean hackers have been linked to a staggering theft of approximately $1.3 billion in cryptocurrencies this year. This figure is alarming as it constitutes over half of the total $2.2 billion stolen worldwide, based on findings from research organizations. The data emphasizes the heightened threat these cybercriminals pose as they have...

Continue Reading
New Addition to Braemar Hotels & Resorts Board Enhances Leadership

Updated Category News Views 68

Braemar Hotels & Resorts Welcomes Jay Shah to the Board Braemar Hotels & Resorts Inc. (NYSE: BHR) is excited to announce that Jay Shah, a seasoned professional in the hospitality and real estate sectors, has joined its Board of Directors as an independent director. This move is set to strengthen the leadership team and enhance the company’s strategic outlook. Jay Shah's...

Continue Reading
Clearside Biomedical's CLS-AX Shows Promising Results in AMD Trials

Updated Category News Views 66

Exciting Developments from Clearside Biomedical Clearside Biomedical, Inc. recently made waves in the medical community by showcasing promising advances in their treatment for age-related macular degeneration (AMD) at a significant ophthalmology event. This biopharmaceutical company is pushing the boundaries with its innovative approach to delivering therapies directly to...

Continue Reading
Titan Mining Reports Remarkable Q3 Earnings and Growth Prospects

Updated Category News Views 186

Titan Mining Corporation Achieves Substantial Q3 Milestones Titan Mining Corporation (TSX: TI, OTCQB: TIMCF) recently unveiled impressive financial and operational performance, highlighting its progress as a rising star in the natural flake graphite sector while maintaining its established capabilities in zinc production. The updates come as the company enters a pivotal...

Continue Reading
Ascent Solar Technologies Leads the Charge in Connectivity Solutions

Updated Category News Views 181

Revolutionizing Connectivity with Innovative Technologies In the evolving landscape of global communication, the demand for efficient and reliable connectivity solutions has never been more crucial. Traditional methods, primarily reliant on satellites and spacecraft, have inherent limitations. These methods can introduce considerable delays in data transmission, making...

Continue Reading